Open | $17.360 |
Close | $17.000 |
Volume / Avg. | 238.361K / 430.782K |
Day Range | 16.960 - 17.800 |
52 Wk Range | 8.920 - 24.500 |
Market Cap | $770.100M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 11.86% |
Days to Cover | 11.36 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioLife Solns (NASDAQ: BLFS) through any online brokerage.
Other companies in BioLife Solns’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), Lifecore Biomedical (NASDAQ:LFCR), Sotera Health (NASDAQ:SHC) and Olink Holding (NASDAQ:OLK).
The latest price target for BioLife Solns (NASDAQ: BLFS) was reported by Craig-Hallum on Thursday, August 10, 2023. The analyst firm set a price target for 23.00 expecting BLFS to rise to within 12 months (a possible 35.29% upside). 5 analyst firms have reported ratings in the last year.
The stock price for BioLife Solns (NASDAQ: BLFS) is $17 last updated March 18, 2024 at 4:20 PM EDT.
There are no upcoming dividends for BioLife Solns.
BioLife Solns’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for BioLife Solns.
BioLife Solns is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.